Cardio Diagnostics Holdings, Inc.CDIOEarnings & Financial Report
Nasdaq
NextMar 30, 2026
CDIO Q3 2025 Key Financial Metrics
Revenue
$2.9K
Gross Profit
N/A
Operating Profit
$-1.7M
Net Profit
$-1.7M
Gross Margin
N/A
Operating Margin
-59950.9%
Net Margin
-60053.8%
YoY Growth
-56.6%
EPS
$-0.98
Financial Flow
Cardio Diagnostics Holdings, Inc. Q3 2025 Financial Summary
Cardio Diagnostics Holdings, Inc. reported revenue of $2.9K for Q3 2025, with a net profit of $-1.7M (-60053.8% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $2.9K |
|---|---|
| Net Profit | $-1.7M |
| Gross Margin | N/A |
| Operating Margin | -59950.9% |
| Report Period | Q3 2025 |
Cardio Diagnostics Holdings, Inc. Annual Revenue by Year
Cardio Diagnostics Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $34.9K).
| Year | Annual Revenue |
|---|---|
| 2024 | $34.9K |
| 2023 | $17.1K |
| 2022 | $950 |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5310 | $15928 | $7870 | $6580 | $4512 | $940 | $7475 | $2855 |
| YoY Growth | 458.9% | N/A | 356.2% | -34.4% | -15.0% | -94.1% | -5.0% | -56.6% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.5M | $4.3M | $4.0M | $4.5M | $10.6M | $12.3M | $10.4M | $8.8M |
| Liabilities | $1.5M | $1.3M | $922529 | $795276 | $1.1M | $904998 | $671848 | $637331 |
| Equity | $3.0M | $3.0M | $3.1M | $3.7M | $9.6M | $11.4M | $9.7M | $8.2M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.7M | $-1.2M | $-1.2M | $-1.2M | $-1.4M | $-1.4M | $-1.6M | $-1.4M |